comparemela.com

Latest Breaking News On - Steripath micro - Page 1 : comparemela.com

Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance

Magnolia Medical Joins Emergency Nurses Association's Corporate Engagement Council as Category-Exclusive Member

®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination 1, announced today that it has become a category-exclusive member of the Emergency Nurses Association (ENA ™) Corporate Engagement Council.   The ENA Corporate Engagement Council (CEC) is designed to support innovation, advances in emergency nursing education, research and advocacy. Together, Magnolia Medical leadership and ENA leaders from the association team, board of directors and key ENA influencers – a mix of businesses, educators and hospitals – will create new opportunities to educate the emergency nursing profession on the most recent advancements in blood culture best practices and sepsis testing accuracy. We are thrilled to partner with the Emergency Nurses Association as an active member of its Corporate Engagement Council, said Greg Bullington, CEO of Magnolia Medical. We look forward to working closely with ENA leadership to further improve patient safety and dr

Steripath-gen
Terrence-sykes
Greg-bullington
Emergency-nurses-association
Magnolia-medical-technologies-inc
Corporate-engagement-council
Stanford-health-care
Magnolia-medical-technologies
Corporate-engagement
Engagement-council
Magnolia-medical
Development-officer-terrence

Magnolia Medical Launches New "Diverted" Multi-Media Advertising Campaign to Educate Healthcare Providers on Benefits of Steripath®

Share this article Share this article SEATTLE, April 14, 2021 /PRNewswire/  Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath ® Initial Specimen Diversion Device ® (ISDD ®) platform. Built around the theme Diverted , the campaign underscores the critical need for the use of Magnolia s ISDD, which diverts the initial 1.5-2.0 mL of blood while maintaining a vein-to-bottle closed system which reduces blood culture contamination rates and false-positive central line-associated bloodstream infections (CLABSI) to improve patient outcomes. (PRNewsfoto/Magnolia Medical Technologies) Diverted embraces bold new creative assets to support a multichannel media campaign that engages healthcare leadership as well as stakeholders within emergency departments, infection prevention, quality, laboratory and nursing. The creative is designed to educate these audiences on the clinical and economic impli

Magnolia-steripath-gen
Steripath-gen
Greg-bullington
Steripath-micro
Clinical-microbiology-reviews
Medical-technologies
Initial-specimen-diversion-technique
Initial-specimen-diversion
Emergency-nursing
Infectious-diseases
Magnolia-medical-technologies

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.